Canopy Growth (NYSE:CGC) is the world’s largest cannabis company, but it isn’t making nearly as much money as Florida’s leading operator of dispensaries. Trulieve Cannabis (NASDAQOTH:TCNNF) took an early lead in the state’s heavily regulated medical marijuana market, and it has a good chance to hold on to that lead.
Trulieve Cannabis enjoys some advantages that Canopy Growth investors can only dream of, and it’s already producing positive cash flows. Here’s why Trulieve stock has a much better chance of outperforming the market than Canopy in the years ahead.
An enviable position
Florida didn’t vote to legalize medical cannabis until 2016, and there are already 207,869 patients with active ID cards that allow them to enter any of the 114 licensed dispensaries across the state and purchase their prescription. Since Canopy Growth listed on a major U.S. stock exchange, it can’t operate south of the border.